Searching for Constitutive Androstane Receptor Modulators
1School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland paavo.honkakoski@uef.fi.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|February 20, 2022
Summary
The constitutive androstane receptor (CAR) regulates drug metabolism and elimination. This review highlights methods for finding CAR modulators, crucial for drug development and toxicity studies.
Area of Science:
- Pharmacology
- Toxicology
- Molecular Biology
Background:
- The constitutive androstane receptor (CAR; NR1I3) is a key xenosensor regulating drug and xenobiotic metabolism.
- CAR influences the expression of drug-metabolizing enzymes and transporters, impacting drug interactions and toxicity.
- Understanding CAR's role is vital for drug development and assessing xenobiotic effects.
Purpose of the Study:
- To review mechanisms modulating CAR activity.
- To introduce recent approaches for identifying and characterizing CAR modulators (agonists, inverse agonists, indirect activators).
- To discuss the significance of CAR modulator discovery for drug development and biological research.
Main Methods:
- Literature review of mechanisms controlling CAR activity.
- Focus on recent screening and characterization methods for CAR agonists, inverse agonists, and indirect activators.
- Discussion of essential features of identified CAR modulators.
Main Results:
- CAR activation leads to increased expression of drug-metabolizing enzymes and transporters.
- Various methods exist for discovering and characterizing CAR modulators.
- CAR modulators are valuable tools for studying CAR's biological functions.
Conclusions:
- Discovery and characterization of CAR modulators are essential for advancing drug development and toxicology.
- Effective methods for identifying CAR modulators are crucial for dissecting CAR's biological roles.
- This review provides insights into current strategies for CAR modulator research.
More Related Videos
Related Concept Videos
The Two-State Receptor Model
2.5K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
2.5K
Transducer Mechanism: Nuclear Receptors
1.8K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.8K
Adrenergic Receptors: ɑ Subtype
2.2K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
2.2K
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
1.1K
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
1.1K
Drug-Receptor Interaction: Agonist
3.0K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
3.0K
Antiasthma Drugs: Muscarinic Receptor Antagonists
630
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
630


